We report our first clinical experiences using this gating technology to treat patients with central lung tumors adjacent to critical structures ... was used when the anatomy matched well with the ...

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

On Saturday, May 3, more than 150 firefighters from five departments across the Atlanta area will join the American Lung Association to raise awareness and critical funds for people living with lung ...

Groundbreaking research from the University of Virginia School of Medicine has revealed crucial new insights into the immune ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Expanding clinical trial infrastructure in community oncology is vital for equitable access to novel therapies, especially in underserved populations. Site management organizations can aid in ...

Margaret and her husband, David, were able to travel to Mexico because a clinical trial drug called zoldonrasib successfully controlled her lung cancer, which had returned after treatment. Dr. Kathryn ...

Electronic "nose" analysis of exhaled breath achieved 80-90% accuracy for detecting lung cancer in patients with suspicious clinical or radiologic findings, a large prospective study showed.

An investigational viral immunotherapy extended survival compared with standard care for patients with advanced non-small cell lung cancer who had inadequate response to immune checkpoint inhibitor ...